An Alabama-based doctor has been charged and has agreed to plead guilty in connection with a $6 million telemedicine fraud scheme involving medically unnecessary durable medical equipment (DME) and genetic testing primarily used to detect mutations in genes that could indicate a higher risk of developing certain types of cancers. Tommie Robinson, 43, has agreed to plead guilty to one count of healthcare fraud. According to the charging documents, between December 2018 and March 2021, Robinson worked with telemedicine companies to sign medical documentation, including doctors’ orders, for medically unnecessary durable medical equipment and genetic testing. It is alleged that these orders signed by Robinson were pre-populated based on telemarketing calls made to Medicare beneficiaries, that Robinson never had any contact with the beneficiaries himself and had no medical relationship with the patients. DME suppliers and laboratories ultimately submitted claims to Medicare for these signed orders. As a result of Robinson’s alleged participation in this scheme, over $6 million in claims were allegedly submitted to Medicare for DME and genetic testing that were medically unnecessary, based on false documentation, and tainted by kickbacks.